Company Filing History:
4 out of 263 
4 out of 987 
2 out of 167 Years Active: 2018-2024
Title: Alexander Bondke: Innovator in Therapeutic Compounds
Introduction
Alexander Bondke is a notable inventor based in Caputh, Germany. He has made significant contributions to the field of therapeutic compounds, particularly in the development of CDK inhibitors. With a total of 5 patents, his work has the potential to impact various medical conditions.
Latest Patents
Among his latest patents, Bondke has developed 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors. This invention focuses on compounds that selectively inhibit cyclin-dependent kinases (CDKs), which are crucial in regulating the cell cycle. The therapeutic applications of these compounds include treating disorders associated with CDK activity, such as cancer, viral infections, neurodegenerative disorders, and autoimmune diseases. Another significant patent involves pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds, which also serve as CDK inhibitors and have similar therapeutic uses.
Career Highlights
Throughout his career, Bondke has worked with prominent organizations, including Cancer Research Technology Limited and Emory University. His research has been pivotal in advancing the understanding of CDK-related disorders and developing innovative treatments.
Collaborations
Bondke has collaborated with esteemed colleagues such as Sebastian Kroll and Anthony Barrett. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Alexander Bondke's innovative work in therapeutic compounds showcases his dedication to advancing medical science. His patents hold promise for treating various serious health conditions, making him a significant figure in the field of pharmacology.